# AppliedXL > AppliedXL builds intelligence infrastructure for the information industry. Its editorial algorithms turn the public record — clinical trial registries, regulatory filings, and other institutional sources — into source-linked signals, indicators, forecasts, and market resolution, delivered before events become news. AppliedXL was founded by computational journalists. Its first vertical is biopharma: machine-scale monitoring of clinical trials and regulatory activity, probability-of-success forecasts, and authoritative event resolution for prediction markets. Contact: support@appliedxl.com. Sitemaps: [Site](https://www.appliedxl.com/sitemap-index.xml) · [News index](https://appliedxl.com/news/sitemap-index.xml) · [News](https://appliedxl.com/news/news-sitemap.xml) ## Platform - [Intelligence Infrastructure for the Information Industry](https://www.appliedxl.com/): AppliedXL turns the public record into verified signals, indicators, and forecasts that enable newsrooms, exchanges, and financial desktops to lead the AI era. - [AXL Core](https://www.appliedxl.com/platform): One system, four layers. The Atlas maps a domain. Four products compute on the map. The trust chain verifies every output. Delivery puts it in your product. - [Turn your domain expertise into AI-ready intelligence.](https://www.appliedxl.com/platform/atlas): AXL Atlas turns the judgment of an expert desk into a structured map of sources, subjects, events, signals, actions, outcomes, and evidence. - [An Atlas in action.](https://www.appliedxl.com/platform/atlas-in-action): Every field and event type in AppliedXL's clinical reference build. An interactive map of the Pharma Industry Atlas: seven layers, from sources to outcomes. - [Every product, in your infrastructure.](https://www.appliedxl.com/platform/delivery): Signals, indicators, forecasts, and resolution delivered through the systems you already run: feeds, APIs, and MCP — point-in-time correct and source-linked. - [The Intelligence Stack](https://www.appliedxl.com/platform/stack): How AXL Core turns the public record into intelligence: the Atlas encodes what’s authoritative, ConteXt runs the map against the record in real time, and the Ledger verifies every determination — powering Signals, Indicators, Forecasts, and Resolution. - [Trust is the product.](https://www.appliedxl.com/platform/trust-chain): Computational journalism applied to commercial intelligence: verification before delivery, corrections on the record, and a visible chain from source to signal. ## Products - [Event probability, learned from history.](https://www.appliedxl.com/forecasts): Forecasts learns which patterns precede which outcomes, and turns today's events into tomorrow's probabilities. - [Recurring events, turned into benchmarks.](https://www.appliedxl.com/indicators): Indicators turns the events Signals detects into measures your clients can't get anywhere else: averages, rates, rankings, and indices. - [Outcomes resolved against the official record.](https://www.appliedxl.com/resolution): Resolution monitors predefined events, verifies the evidence, and produces documented outcome analysis for exchange settlement. - [Material change, detected before consensus.](https://www.appliedxl.com/signals): Signals reads the official records in your domain and turns material change into the alerts, briefings, and news your product delivers. ## Solutions - [Built for the companies that create intelligence.](https://www.appliedxl.com/solutions): Turn primary evidence into proprietary signals your clients can trust, act on, and feed into machines. - [Benchmarks from institutional events.](https://www.appliedxl.com/solutions/exchanges): Benchmarks and indices built from institutional events: AppliedXL turns verified public-record changes into computable benchmarks for exchanges and index providers. - [Specialized feeds your terminal doesn't have yet.](https://www.appliedxl.com/solutions/financial-desktops): Specialized event feeds for financial desktops and terminals: source-linked biopharma signals, indicators, and forecasts delivered ahead of the news cycle. - [Your beats, monitored at machine scale.](https://www.appliedxl.com/solutions/newsrooms): AppliedXL monitors your beats at machine scale: verified, source-linked event detection that gives newsroom reporters a head start on the public record. - [More markets. Authoritative resolution.](https://www.appliedxl.com/solutions/prediction-markets): More markets with authoritative resolution: AppliedXL supplies event definitions, live probabilities, and source-linked settlement for prediction markets. - [Risk, detected before the balance sheet.](https://www.appliedxl.com/solutions/ratings-risk): Risk detected before the balance sheet: AppliedXL surfaces early, source-linked risk signals for ratings and risk intelligence providers. - [Deep coverage without linear analyst growth.](https://www.appliedxl.com/solutions/specialist-providers): Deep vertical coverage without linear analyst growth: AppliedXL event detection expands specialist information products at machine scale. ## Themes - [Where new information markets appear first.](https://www.appliedxl.com/themes): When a change is coming, the record moves before the market does. AppliedXL maps the sources, entities, events, and outcomes behind that change. - [Infrastructure intelligence for the AI economy.](https://www.appliedxl.com/themes/ai-infrastructure): AppliedXL tracks power, land, interconnection, and data-center buildout records, giving investors verified early signals on AI infrastructure capacity. - [Supply intelligence for strategic capacity.](https://www.appliedxl.com/themes/critical-materials): AppliedXL monitors mining, processing, and supply-chain records for critical materials, surfacing verified signals on the industrial buildout ahead of the news. - [Project intelligence for the energy transition.](https://www.appliedxl.com/themes/energy-transition): AppliedXL monitors permits, grid filings, and project records across the energy transition, turning fragmented public data into verified market signals. - [Clinical intelligence for medical innovation.](https://www.appliedxl.com/themes/human-health): AppliedXL tracks clinical trials, FDA decisions, and drug-development milestones at machine scale, delivering verified biopharma signals before the news cycle. - [Institutional intelligence for emerging risk.](https://www.appliedxl.com/themes/systemic-risk): AppliedXL detects enforcement actions, sanctions, cyber incidents, and trade controls in the public record, delivering early source-linked signals on emerging systemic risk. ## Research - [Research and Insights](https://www.appliedxl.com/research): Research and insights from AppliedXL: theses, benchmarks, and case studies on computational journalism, event detection, and forecasting for the information industry. - [AppliedXL and Bain: A New Pharma Operating Discipline](https://www.appliedxl.com/research/appliedxl-bain-operating-discipline): A combined framework that pairs real-time AI monitoring with strategic analysis, turning clinical-trial execution into a measurable operational advantage. - [AppliedXL Partners with Bloomberg](https://www.appliedxl.com/research/appliedxl-bloomberg-partnership): Bloomberg Terminal users now have access to AppliedXL's AI-generated coverage of clinical trials, built to surface catalyst events in the pharmaceutical pipeline. - [AppliedXL and Kalshi Partner on Biopharma Prediction Markets](https://www.appliedxl.com/research/appliedxl-kalshi-partnership): The program introduces contracts tied to selected clinical trial outcomes and FDA decisions, supported by structured public evidence and predefined resolution criteria. - [Vertical AI vs. General AI: Biopharma Benchmark](https://www.appliedxl.com/research/appliedxl-vs-claude-chatgpt-perplexity-biopharma): A head-to-head benchmark of AppliedXL against Claude, ChatGPT, and Perplexity on real biopharma research tasks, measuring depth, domain reasoning, and accuracy. - [Biopharma's Public Probability](https://www.appliedxl.com/research/biopharma-public-probability): A new report from Kalshi and AppliedXL on the state and future of prediction markets in drug development — and what happens when expectations become public prices. - [Biopharma's Public Probability — AppliedXL & Kalshi](https://www.appliedxl.com/research/biopharma-public-probability-report): The State and Future of Prediction Markets in Drug Development. The full web edition of the joint AppliedXL and Kalshi report on biopharma prediction markets. - [Clinical Trial Data as Alpha: Biotech Quant Model](https://www.appliedxl.com/research/clinical-trial-alpha-quant-model): AppliedXL built a biotech quant investing model on point-in-time clinical trial data enriched with SEC filings, press releases, and AI agents. - [State-of-the-Art Clinical Trial Prediction](https://www.appliedxl.com/research/clinical-trial-prediction): Clinical trials don't just succeed or fail. They pass through five sequential checkpoints, and failure can concentrate at any one of them. - [FDA Drug Repurposing: 5 Drugs Without a Champion](https://www.appliedxl.com/research/fda-drug-repurposing-intelligence): The FDA opened a public docket requesting input on drug repurposing opportunities where commercial incentives are insufficient to drive new applications. - [The Hidden Signals That Decide Drug Success or Failure](https://www.appliedxl.com/research/hidden-signals-drug-success-failure): AppliedXL decodes subtle shifts in clinical trials flagging risks and opportunities before they hit the news cycle. - [From Public Record to Market Resolution](https://www.appliedxl.com/research/how-a-market-resolves): How a fact becomes a settlement: an illustrative walkthrough of AppliedXL's resolution process for event markets — public-record monitoring, curation, contract terms, evidence review, human sign-off, and the exchange's independent outcome review. - [Original Intelligence](https://www.appliedxl.com/research/original-intelligence): For two centuries, information companies were paid for two things at once: originating what is true, and delivering it. AI has split the bundle and priced the halves at opposite extremes. Delivery is becoming a commodity. Origination is becoming the whole business. - [Prediction Model: Six Clinical Trial Case Studies](https://www.appliedxl.com/research/prediction-model-six-clinical-trial-case-studies): Six clinical trials tracked from first filing to outcome. - [The Readout Gap](https://www.appliedxl.com/research/readout-gap): A study of 681 clinical trials found the dates companies give for results are usually missed — and when they slip, far more often late than early. - [Seeing Risk Before It Becomes News](https://www.appliedxl.com/research/seeing-risk-before-news): Execution failures rarely appear suddenly. They build quietly inside clinical programs until they spill into earnings calls, regulatory filings, or headlines. - [Spillover Risk and Readthrough Alpha](https://www.appliedxl.com/research/spillover-risk-readthrough-alpha): Registry anomalies precede press releases by 48-72 hours. - [Systematic Trading Strategies in Biotech](https://www.appliedxl.com/research/systematic-trading-strategies-biotech): Exploratory research on using structured clinical trial event data for alpha generation: early instability detection, mechanistic readthrough, and more. - [Who Will Monetize Truth? A Thesis For the Future of Information](https://www.appliedxl.com/research/who-will-monetize-truth): A thesis for the future of the information business: the news industry is being repriced around companies that sell awareness versus those that sell action. ## Company - [Important change is visible before it is obvious.](https://www.appliedxl.com/about): AppliedXL brings the standards of a newsroom to the scale of a machine — reading the public record to see material change before the market prices it. - [The Science of First](https://www.appliedxl.com/book): A book about seeing what others miss. Francesco Marconi shows how early signals in data, behavior, and narrative reveal the shifts that matter before they become news. - [Power new intelligence.](https://www.appliedxl.com/contact): Tell us the domain you want to move on, and we will scope a working sample on your records, delivered through your product, under your brand. ## Legal - [Privacy Policy](https://www.appliedxl.com/privacy): How Applied X Lab, Inc. collects, uses, and shares personal information through our website, platform, and related services. - [Terms of Use](https://www.appliedxl.com/terms): The Terms of Use governing access to AppliedXL.com and AppliedXL’s website content, operated by Applied X Lab, Inc. ## Other - [Intelligence Strategy Assessment](https://www.appliedxl.com/assessment): Take the 3-minute assessment and we'll build your customized intelligence strategy playbook — an executive report on turning your domain expertise into original information no competitor has. - [AppliedXL Biotech — The biotech record, before it's news.](https://www.appliedxl.com/biotech): AppliedXL Biotech turns the public biopharma record into decisions. Probability of Success with 88% directional accuracy, execution risk, trial timelines, live landscapes, competitive intelligence, catalyst calendar, a 5-year point-in-time record, real-time alerts, and a biopharma agent. - [AI Editorial Policy](https://www.appliedxl.com/editorial-policy): AppliedXL's AI Editorial Policy: the standards that govern our editorial systems — curated primary sources, traceable provenance, algorithmic accuracy checks, human oversight, and editorial independence. - [FAQ — Biopharma Prediction Markets](https://www.appliedxl.com/faq-resolution-event-contracts): Frequently asked questions about the Kalshi–AppliedXL partnership, biopharma prediction markets, how resolution works, and the safeguards behind the markets. - [Going Live — See results in days. Fully launched in weeks.](https://www.appliedxl.com/going-live): Not a six-month integration. The system maps your domain to an Atlas, encodes the editorial judgment for your audience, and delivers verified product through the trust chain — a working use case in days, production in weeks. - [Media & Partnerships](https://www.appliedxl.com/media): Press inquiries, partnership proposals, and speaking requests for AppliedXL. Reach the team directly. - [Site Map](https://www.appliedxl.com/sitemap): A complete index of every page on appliedxl.com — platform, products, solutions, themes, research, and company pages. ## Live Exploration - [Biopharma News](https://appliedxl.com/news): The wire — AI-generated clinical trial and regulatory coverage, in production. - [Pharma Forecast Platform](https://appliedxl.ai/): Clinical trial probability of success and regulatory approval forecasts, live.